Digestive vacuole of Plasmodium falciparum released during erythrocyte rupture dually activates complement and coagulation

Blood

Volumn 119, Issue 18, 2012, Pages 4301-4310

  Dasari, Prasad ^a   Heber, Sophia D ^a   Beisele, Maike ^a   Torzewski, Michael ^b   Reifenberg, Kurt ^a   Orning, Carolin ^a   Fries, Anja ^a   Zapf, Anna Lena ^a   Baumeister, Stefan ^c   Lingelbach, Klaus ^c   Udomsangpetch, Rachanee ^d   Bhakdi, Sebastian Chakrit ^d   Reiss, Karina ^e   Bhakdi, Sucharit ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d Johannes Gutenberg University Mainz ^*  (Thailand)

^e UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; HEMOZOIN; PHOSPHOLIPASE C; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CELL ORGANELLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; DIGESTIVE VACUOLE; ERYTHROCYTE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALARIA; MALE; NOCICEPTION; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RAT; ULTRASOUND;

EID: 84860736934     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-11-392134     Document Type: Article

References (52)

1. Berendt AR, Tumer GD, Newbold CI. Cerebral malaria: The sequestration hypothesis. Parasitol Today. 1994;10(10):412-414. (Pubitemid 24306851)
2. Clark IA, Cowden WB. The pathophysiology of falciparum malaria. Pharmacol Ther. 2003;99(2): 221-260. (Pubitemid 36897750)
3. Moxon CA, Heyderman RS, Wassmer SC. Dysregulation of coagulation in cerebral malaria. Mol Biochem Parasitol. 2009;166(2):99-108.
4. van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE. A unified hypothesis for the genesis of cerebral malaria: Sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 2006; 22(11):503-508. (Pubitemid 44479847)
5. Francischetti IM, Seydel KB, Monteiro RQ. Blood coagulation, inflammation, and malaria. Microcirculation. 2008;15(2):81-107. (Pubitemid 351228635)
6. Neva FA, Howard WA, Glew RH, et al. Relationship of serum complement levels to events of the malarial paroxysm. J Clin Invest. 1974;54(2):451-460.
7. Glew RH, Atkinson JP, Frank MM, Collins WE, Neva FA. Serum complement and immunity in experimental simian malaria. I. Cyclical alterations in C4 related to schizont rupture. J Infect Dis. 1975;131(1):17-25.
8. Helegbe GK, Goka BQ, Kurtzhals JA, et al. Complement activation in Ghanaian children with severe Plasmodium falciparum malaria. Malar J. 2007;6:165.
9. Roestenberg M, McCall M, Mollnes TE, et al. Complement activation in experimental human malaria infection. Trans R Soc Trop Med Hyg. 2007;101(7):643-649. (Pubitemid 46706153)
10. Patel SN, Berghout J, Lovegrove FE, et al. C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. J Exp Med. 2008; 205(5):1133-1143. (Pubitemid 351679688)
11. Ramos TN, Darley MM, Hu X, et al. Cutting edge: The membrane attack complex of complement is required for the development of murine experimental cerebral malaria. J Immunol. 2011; 186(12):6657-6660.
12. Pagola S, Stephens PW, Bohle DS, Kosar AD, Madsen SK. The structure of malaria pigment beta-haematin. Nature. 2000;404(6775):307-310.
13. Jaramillo M, Plante I, Ouellet N, Vandal K, Tessier PA, Olivier M. Hemozoin-inducible proinflammatory events in vivo: Potential role in malaria infection. J Immunol. 2004;172(5):3101-3110. (Pubitemid 38263700)
14. Prato M, Giribaldi G, Polimeni M, Gallo V, Arese P. Phagocytosis of hemozoin enhances matrix metalloproteinase- 9 activity and TNF-alpha production in human monocytes: Role of matrix metalloproteinases in the pathogenesis of falciparum malaria. J Immunol. 2005;175(10):6436-6442. (Pubitemid 41598884)
15. Pawluczkowycz AW, Lindorfer MA, Waitumbi JN, Taylor RP. Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: Potential implications for the pathogenesis of anemia in malaria. J Immunol. 2007;179(8):5543-5552.
16. Bulmer JN, Rasheed FN, Francis N, Morrison L, Greenwood BM. Placental malaria. I. Pathological classification. Histopathology. 1993;22(3):211-218. (Pubitemid 23105129)
17. Bannister LH, Hopkins JM, Fowler RE, Krishna S, Mitchell GH. A brief illustrated guide to the ultrastructure of Plasmodium falciparum asexual blood stages. Parasitol Today. 2000;16(10):427-433.
18. Abkarian M, Massiera G, Berry L, Roques M, Braun-Breton C. A novel mechanism for egress of malarial parasites from red blood cells. Blood. 2011;117(15):4118-4124.
19. Dasari P, Reiss K, Lingelbach K, et al. Digestive vacuoles of Plasmodium falciparum are selectively phagocytosed by and impair killing function of polymorphonuclear leukocytes. Blood. 2011; 118(18):4946-4956.
20. Hugo F, Kramer S, Bhakdi S. Sensitive ELISA for quantitating the terminal membrane C5b-9 and fluid-phase SC5b-9 complex of human complement. J Immunol Methods. 1987;99(2):243-251. (Pubitemid 17089351)
21. Blackman MJ, Heidrich HG, Donachie S, McBride JS, Holder AA. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med. 1990;172(1):379-382. (Pubitemid 20217284)
22. Blackman MJ, Scott-Finnigan TJ, Shai S, Holder AA. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J Exp Med. 1994;180(1):389-393. (Pubitemid 24181090)
23. Salmon BL, Oksman A, Goldberg DE. Malaria parasite exit from the host erythrocyte: A two-step process requiring extraerythrocytic proteolysis. Proc Natl Acad Sci U S A. 2001;98(1):271-276. (Pubitemid 32095899)
24. Bhakdi S, Torzewski M, Paprotka K, et al. Possible protective role for C-reactive protein in atherogenesis: Complement activation by modified lipoproteins halts before detrimental terminal sequence. Circulation. 2004;109(15):1870-1876. (Pubitemid 38509122)
25. Shi J, Gilbert GE. Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites. Blood. 2003;101(7): 2628-2636. (Pubitemid 36857623)
26. Woolfe G, McDonald AD. The evaluation of the analgesic action of pethidine hydrochloride (Demerol). J Pharmacol Exp Ther. 1944;80:300-307.
27. Saliba KJ, Folb PI, Smith PJ. Role for the plasmodium falciparum digestive vacuole in chloroquine resistance. Biochem Pharmacol. 1998;56(3):313-320. (Pubitemid 28473206)
28. Dluzewski AR, Ling IT, Hopkins JM, et al. Formation of the food vacuole in Plasmodium falciparum: A potential role for the 19 kDa fragment of merozoite surface protein 1 (MSP1(19)). PLoS One. 2008;3(8):e3085.
29. Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol. 2009;9(10): 729-740.
30. Goldberg DE, SlaterAF, Cerami A, Henderson GB. Hemoglobin degradation in the malaria parasite Plasmodium falciparum: An ordered process in a unique organelle. Proc Natl Acad Sci U S A. 1990;87(8):2931-2935.
31. Clemens R, Pramoolsinsap C, Lorenz R, Pukrittayakamee S, Bock HL, White NJ. Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway. Br J Haematol. 1994;87(1):100-105. (Pubitemid 24207006)
32. Francischetti IM, Seydel KB, Monteiro RQ, et al. Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes. J Thromb Haemost. 2007; 5(1):155-165. (Pubitemid 44921081)
33. Wuillemin WA, te Velthuis H, Lubbers YT, de Ruig CP, Eldering E, Hack CE. Potentiation of C1 inhibitor by glycosaminoglycans: Dextran sulfate species are effective inhibitors of in vitro complement activation in plasma. J Immunol. 1997;159(4):1953-1960. (Pubitemid 127484185)
34. Wuillemin WA, Eldering E, Citarella F, de Ruig CP, ten Cate H, Hack CE. Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa. J Biol Chem. 1996;271(22):12913- 12918. (Pubitemid 26175865)
35. Anderson JA, Fredenburgh JC, Stafford AR, et al. Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase. J Biol Chem. 2001;276(13):9755-9761.
36. Johansson H, Goto M, Dufrane D, et al. Low molecular weight dextran sulfate: A strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant. 2006;6(2):305-312. (Pubitemid 43382165)
37. Schmidt P, Magnusson C, Lundgren T, Korsgren O, Nilsson B. Low molecular weight dextran sulfate is well tolerated in humans and increases endogenous expression of islet protective hepatocyte growth factor. Transplantation. 2008;86(11):1523-1530.
38. Hartwig CL, Rosenthal AS, D'Angelo J, Griffin CE, Posner GH, Cooper RA. Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide- dependent. Biochem Pharmacol. 2009;77(3):322-336.
39. Medof ME, Kinoshita T, Nussenzweig V. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med. 1984; 160(5):1558-1578. (Pubitemid 15220783)
40. Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JP. Control of the complement system. Adv Immunol. 1996;61:201-283. (Pubitemid 26065042)
41. Murphy SC, Hiller NL, Harrison T, Lomasney JW, Mohandas N, Haldar K. Lipid rafts and malaria parasite infection of erythrocytes. Mol Membr Biol. 2006;23(1):81-88.
42. Lauer S, VanWye J, Harrison T, et al. Vacuolar uptake of host components, and a role for cholesterol and sphingomyelin in malarial infection. EMBO J. 2000;19(14):3556-3564. (Pubitemid 30462114)
43. Murphy SC, Samuel BU, Harrison T, et al. Erythrocyte detergent-resistant membrane proteins: Their characterization and selective uptake during malarial infection. Blood. 2004;103(5):1920-1928. (Pubitemid 38268992)
44. Haldar K, Samuel BU, Mohandas N, Harrison T, Hiller NL. Transport mechanisms in Plasmodiuminfected erythrocytes: Lipid rafts and a tubovesicular network. Int J Parasitol. 2001;31(12):1393-1401. (Pubitemid 32868718)
45. Ward PA, Gao H. Sepsis, complement and the dysregulated inflammatory response. J Cell Mol Med. 2009;13(10):4154-4160.
46. Smedegård G, Cui LX, Hugli TE. Endotoxininduced shock in the rat. A role for C5a. Am J Pathol. 1989;135(3):489-497. (Pubitemid 19246207)
47. Wickramasinghe SN, Phillips RE, Looareesuwan S, Warrell DA, Hughes M. The bone marrow in human cerebral malaria: Parasite sequestration within sinusoids. Br J Haematol. 1987;66(3):295-306. (Pubitemid 17095286)
48. Schwarzer E, Turrini F, Ulliers D, Giribaldi G, Ginsburg H, Arese P. Impairment of macrophage functions after ingestion of Plasmodium falciparum- infected erythrocytes or isolated malarial pigment. J Exp Med. 1992;176(4):1033-1041.
49. Skorokhod OA, Alessio M, Mordmuller B, Arese P, Schwarzer E. Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte- derived dendritic cells: A peroxisome proliferator- activated receptor-gamma-mediated effect. J Immunol. 2004;173(6):4066-4074. (Pubitemid 39280771)
50. Giribaldi G, Prato M, Ulliers D, et al. Involvement of inflammatory chemokines in survival of human monocytes fed with malarial pigment. Infect Immun. 2010;78(11):4912-4921.
51. Zhu Z, Atkinson TP, Hovanky KT, et al. High prevalence of complement component C6 deficiency among African-Americans in the southeastern USA. Clin Exp Immunol. 2000;119(2): 305-310. (Pubitemid 30073034)
52. Clark DL, Su S, Davidson EA. Saccharide anions as inhibitors of the malaria parasite. Glycoconj J. 1997;14(4):473-479. (Pubitemid 27289442)